2′-Deoxy-2′-α-fluoro-2′-β-C-methyl 3′,5′-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: Discovery of PSI-352938

被引：47

作者：

Reddy, P. Ganapati ^{[1
]}

Bao, Donghui ^{[1
]}

Chang, Wonsuk ^{[1
]}

Chun, Byoung-Kwon ^{[1
]}

Du, Jinfa ^{[1
]}

Nagarathnam, Dhanapalan ^{[1
]}

Rachakonda, Suguna ^{[1
]}

Ross, Bruce S. ^{[1
]}

Zhang, Hai-Ren ^{[1
]}

Bansal, Shalini ^{[1
]}

Espiritu, Christine L. ^{[1
]}

Keilman, Meg ^{[1
]}

Lam, Angela M. ^{[1
]}

Niu, Congrong ^{[1
]}

Steuer, Holly Micolochick ^{[1
]}

Furman, Phillip A. ^{[1
]}

Otto, Michael J. ^{[1
]}

Sofia, Michael J. ^{[1
]}

机构：

[1] Pharmasset Inc, Princeton, NJ 08540 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 24期

关键词：

Antiviral; HCV; Nucleoside; Prodrug; Cyclic Phosphate; C VIRUS-REPLICATION; ANTIVIRAL ACTIVITY; HUH-7; CELLS; EFFICIENT; REPLICON; RING; MONOPHOSPHATE; DESIGN;

D O I：

10.1016/j.bmcl.2010.10.035

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel 2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs were synthesized and evaluated for their in vitro anti-HCV activity and safety. These prodrugs demonstrated a 10-100-fold greater potency than the parent nucleoside in a cell-based replicon assay due to higher cellular triphosphate levels. Our structure-activity relationship (SAR) studies provided compounds that gave high levels of active triphosphate in rat liver when administered orally to rats. These studies ultimately led to the selection of the clinical development candidate 24a (PSI-352938). (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：7376 / 7380

页数：5

共 50 条

[31] Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors
Randolph, John T.
Li, Tongmei
Krueger, A. Chris
Heyman, Howard R.
Chen, Hui-Ju
Bow, Daniel A. J.
Van Handel, Cecilia
Peterkin, Vincent
Carr, Robert A.
Stolarik, DeAnne
Dekhtyar, Tatyana
Irvin, Michelle
Krishnan, Preethi
Wagner, Rolf
DeGoey, David A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (07)
[32] Discovery of N-Arylalkyl-3-hydroxy-4-oxo-3,4-dihydroquinazolin-2-carboxamide Derivatives as HCV NS5B Polymerase Inhibitors
Deore, Ravindra Ramesh
Chen, Grace Shiahuy
Chang, Pei-Teh
Chern, Ting-Rong
Lai, Shin-Yu
Chuang, Ming-Hsieh
Lin, Jung-Hsin
Kung, Fan-Lu
Chen, Chien-Shu
Chiou, Chun-Tang
Chern, Ji-Wang
CHEMMEDCHEM, 2012, 7 (05) : 850 - 860
[33] Non-nucleoside Inhibitors of NS5B Polymerase from HCV, Genotypes 1b and 2a
James, Michael
Biswal, Bichitra
Wang, Meitian
Cherney, Maia
Chan, Laval
Yannopoulos, Constantin
Bilimoria, Darius
Nicolas, Olivier
Bedard, Jean
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C50 - C50
[34] Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′-C-methyluridine 5′-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection
Wang, Guangyi
Dyatkina, Natalia
Prhavc, Marija
Williams, Caroline
Serebryany, Vladimir
Hu, Yujian
Huang, Yongfei
Wan, Jinqiao
Wu, Xiangyang
Deval, Jerome
Fung, Amy
Jin, Zhinan
Fan, Hua
Shaw, Kenneth
Kang, Hyunsoon
Zhang, Qingling
Tam, Yuen
Stoycheva, Antitsa
Jekle, Andreas
Smith, David B.
Beigelman, Leonid
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (09) : 4555 - 4570
[35] Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
Ruebsam, Frank
Murphy, Douglas E.
Tran, Chinh V.
Li, Lian-Sheng
Zhao, Jingjing
Dragovich, Peter S.
McGuire, Helen M.
Xiang, Alan X.
Sun, Zhongxiang
Ayida, Benjamin K.
Blazel, Julie K.
Kim, Sun Hee
Zhou, Yuefen
Han, Qing
Kissinger, Charles R.
Webber, Stephen E.
Showalter, Richard E.
Shah, Amit M.
Tsan, Mei
Patel, Rupal A.
Thompson, Peggy A.
LeBrun, Laurie A.
Hou, Huiying J.
Kamran, Ruhi
Sergeeva, Maria V.
Bartkowski, Darian M.
Nolan, Thomas G.
Norris, Daniel A.
Khandurina, Julia
Brooks, Jennifer
Okamoto, Ellen
Kirkovsky, Leo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (22) : 6404 - 6412
[36] Syntheses of nucleosides with 2′-spirolactam and 2′-spiropyrrolidine moieties as potential inhibitors of hepatitis C virus NS5B polymerase
Dang, Qun
Zhang, Zhibo
Tang, Bingyu
Song, Yang
Wu, Ling
Chen, Tongqian
Bogen, Stephane
Girijavallabhan, Vinay
Olsen, David B.
Meinke, Peter T.
TETRAHEDRON LETTERS, 2014, 55 (28) : 3813 - 3816
[37] 5′-triphosphate of 7-deaza-7-ethynyl-2′-deoxy-2′-fluoro-2′-C-methyladenosine:: New potent chain terminator of hepatitis C virus RNA polymerase
Dyatkina, Natalia
Prhavc, Marija
Keicher, Jesse
Liehr, Sebastian
Koo-Mccoy, Samantha
Latour, Derek
Fung, Kevin
Pouliot, Jeff
Wang, Ting
Li, Wenbao
Lou, Lillian
Roberts, Christopher
Griffith, Ron
CHEMISTRY OF NUCLEIC ACID COMPONENTS, 2008, 10 : 341 - 342
[38] 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase
Kucukguzel, Ilkay
Satilmis, Gokhan
Gurukumar, K. R.
Basu, Amartya
Tatar, Esra
Nichols, Daniel B.
Talele, Tanaji T.
Kaushik-Basu, Neerja
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 69 : 931 - 941
[39] 2-(2-thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: Discovery, SAR, modeling, and mutagenesis
Koch, U
Attenni, B
Malancona, S
Colarusso, S
Conte, I
Di Filippo, M
Harper, S
Pacini, B
Giomini, C
Thomas, S
Incitti, I
Tomei, L
De Francesco, R
Altamura, S
Matassa, VG
Narjes, F
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (05) : 1693 - 1705
[40] Concise syntheses and HCV NS5B polymerase inhibition of (2′R)-3 and (2′S)-2′-ethynyluridine-10 and related nucleosides
Bennett, Frank
Buevich, Alexei V.
Huang, Hsueh-Cheng
Girijavallabhan, Vinay
Kerekes, Angela D.
Huang, Yuhua
Malikzay, Asra
Smith, Elizabeth
Ferrari, Eric
Senior, Mary
Osterman, Rebecca
Wang, Lingyan
Wang, Jun
Pu, Haiyan
Truong, Quang T.
Tawa, Paul
Bogen, Stephane L.
Davies, Ian W.
Weber, Ann E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (23) : 5349 - 5352

← 1 2 3 4 5 →